| 000 | 01068 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515035022.0 | ||
| 264 | 0 | _c20060822 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(06)69128-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDore, Gregory J | |
| 245 | 0 | 0 |
_aHAART's first decade: success brings further challenges. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cAug 2006 |
||
| 300 |
_a427-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xmortality |
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xstatistics & numerical data |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aTuberculosis _xmortality |
| 700 | 1 | _aCooper, David A | |
| 773 | 0 |
_tLancet (London, England) _gvol. 368 _gno. 9534 _gp. 427-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(06)69128-9 _zAvailable from publisher's website |
| 999 |
_c16479041 _d16479041 |
||